BMY | tickerfilter.com

Fundamental analysis

32%

Profitability 7%

Dept financing 49%

Liquidity 74%

Performance 42%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.23%

1 Month

6.86%

3 Months

7.22%

6 Months

21.74%

1 Year

13.60%

2 Year

-9.38%

Key data

Stock price

$59.81

P/E Ratio

0.00

DAY RANGE

$59.52 - $60.82

EPS

-$4.41

52 WEEK RANGE

$39.35 - $63.33

52 WEEK CHANGE

$13.95

MARKET CAP

113.461 B

YIELD

4.29%

SHARES OUTSTANDING

2.027 B

DIVIDEND

$0.60

EX-DIVIDEND DATE

07-05-2024

NEXT EARNINGS DATE

N/A

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$14,047,646

AVERAGE 30 VOLUME

$12,350,752

Company detail

CEO: Giovanni Caforio
Region: US
Website: bms.com
Employees: 34,300
IPO year: 1972

Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma.

BMY - BRISTOL MYERS SQUIBB CO